
Sign up to save your podcasts
Or
If 2023 was the year weight-loss injections such as Ozempic or WeGovy took over Hollywood, then 2024 was the year they went global. What does that mean for Novo Nordisk, the Danish company making them? And can it live up to the hype?
Writer: Claudia Williams
Producer: Claudia Williams
Photography: Joe Mee
Executive producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.
4.5
1212 ratings
If 2023 was the year weight-loss injections such as Ozempic or WeGovy took over Hollywood, then 2024 was the year they went global. What does that mean for Novo Nordisk, the Danish company making them? And can it live up to the hype?
Writer: Claudia Williams
Producer: Claudia Williams
Photography: Joe Mee
Executive producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.
247 Listeners
832 Listeners
127 Listeners
674 Listeners
202 Listeners
998 Listeners
167 Listeners
262 Listeners
4 Listeners
29 Listeners
72 Listeners
3,419 Listeners
52 Listeners
207 Listeners
3,289 Listeners
6 Listeners
13 Listeners
54 Listeners
983 Listeners
1,130 Listeners
57 Listeners
13 Listeners
13 Listeners
49 Listeners
38 Listeners
492 Listeners
1 Listeners
4 Listeners
6 Listeners
12 Listeners
158 Listeners